✦ LIBER ✦

Potent CYP17 inhibitors: improved syntheses, pharmacokinetics and anti-tumor activity in the LNCaP human prostate cancer model

✍ Scribed by Venkatesh D. Handratta; Danijela Jelovac; Brian J. Long; Ritesh Kataria; Ivo P. Nnane; Vincent C.O. Njar; Angela M.H. Brodie

Book ID: 116697453
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 574 KB
Volume: 92
Category: Article
ISSN: 0960-0760
DOI: 10.1016/j.jsbmb.2004.07.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel C-17-Heteroaryl Steroidal CYP17 In

Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens: Synthesis, in Vitro Biological Activity, Pharmacokinetics, and Antitumor Activity in the LAPC4 Human Prostate Cancer Xenograft Model

✍ Handratta, Venkatesh D.; Vasaitis, Tadas S.; Njar, Vincent C. O.; Gediya, Lalji 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 307 KB

MP70-05 ANTI-CANCER ACTIVITY OF THE SELE

MP70-05 ANTI-CANCER ACTIVITY OF THE SELECTIVE CYP17A1 INHIBITOR, VT-464, IN PRE-CLINICAL MODELS OF CASTRATE RESISTANT PROSTATE CANCER

✍ Toren, Paul; Pham, Steven; Kim, Soojin; Adomat, Hans; Zoubeidi, Amina; Moore, Wi 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 162 KB

158 POSTER Abiraterone acetate (AA), an

158 POSTER Abiraterone acetate (AA), an irreversible inhibitor of CYP17, has significant and durable anti-tumor activity in both chemotherapy- naive and docetaxel treated castration-resistant prostate cancer (CRPC)

✍ G. Attard; A. Reid; N. Babu Oommen; L. Folkerd; D. Olmos; E. Thompson; G. Maier; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

368 GDC-0068, a Novel and Selective Akt

368 GDC-0068, a Novel and Selective Akt Inhibitor Demonstrates Improvement in Anti-tumor Activity When Combined with Androgen Receptor Pathway Antagonists, MDV3100 and Abiraterone, in Prostate Cancer Models

✍ Nannini, M.A.; Arrazate, A.; Bower, J.; Lee, L.B.; Lin, J.; Lee, B.B.; Kassees, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 76 KB